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Abstract 
Background and objectives 
TB case detection in Tanzania is mainly through passive case finding, however, it has 
remained below the WHO and national target of 70%. Several studies have 
investigated different strategies to increase TB case finding and how to reduce TB 
diagnostic and treatment delay. A study conducted in Brazil showed that the 
probability of having TB did not depend on cough duration. Moreover, interventions 
aimed at integrating passive TB case finding in other clinics like antenatal clinics 
have proven to be acceptable and have also been recommended in Malawi and South 
Africa. Active case finding for TB revealed a significant number of undiagnosed TB 
cases among women attending PMTCT clinics in South Africa. Still, delay in 
diagnosis and treatment is a challenge, and case detection remains low, especially 
among women. Therefore, this thesis is based on studies that were conducted to 
determine the following:  
i) the proportion of smear positive TB among patients with cough attending 
OPD, FP and MCH clinics in Dar es Salaam, regardless of the duration of 
cough (paper I and II) 
ii)   the extent of, and factors responsible for delay in TB case detection in Pwani 
region (paper III)  
iii)  the cost associated with TB healthcare seeking for the current passive case 
finding strategy in Dar es Salaam (paper IV).  
 
Study design and Setting 
We conducted a cross sectional hospital based study in Dar es Salaam and Pwani 
region between 2007 and 2008. The two regions are adjacent to each other and are 
located along the coastal area of Tanzania, and share cultural values. Dar es Salaam 
and Pwani have a total population of 2,497,940 and 889,154 respectively.  
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Study participants and data analysis 
Study participants for detection of pulmonary tuberculosis among patients with cough 
attending OPD (paper I) involved patients aged 5 years and above. Study participants 
for paper II were women aged 15 years and above attending MCH and FP clinics 
with a cough. We actively asked for a cough, all study participants from FP and MCH 
clinics. All participants included in paper I and II were screened for TB by sputum 
microscopy, regardless of the duration of cough. Study participants for paper III were 
smear positive TB patients diagnosed to have TB within three months prior to the 
commencement of the study. The study for paper IV involved patients aged 15 years 
and above and who have just been diagnosed to have TB.  We trained all research 
assistants. Questionnaires were pre tested. The outcome variables included: diagnosis 
of smear positive TB, magnitude of TB diagnostic delay and risk factors associated 
with delay as well as patients and households cost before TB diagnosis. We explored 
possible associations between cough duration and smear results, clinic of diagnosis, 
place of first presentation and number of visits made prior to diagnosis. The main 
methods for analysis were cross tabulation and bivariate logistic regression. We 
applied the following statistical tests to determine estimated proportions and risk 
factors: odds ratios, means and medians, Pearson Chi- square, Wald statistic and 95% 
CI. 
Results 
The study involved 3,372 patients: 2274 patients with cough attending OPD; 749 
women with cough attending FP and MCH clinics; 226 smear positive pulmonary 
tuberculosis patients from DOTS clinics and 123 TB patients who have just been 
diagnosed to have TB. 
The probability of being smear positive does not depend on cough duration. Out of 
2274 patients with cough, regardless of the duration, and attending OPD, 2214 
(97.4%) remembered their cough duration. One thousand nine hundred and seventy 
three patients (89.1%) coughed for two weeks or more compared to 241 (10.9%) 
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patients who coughed for less than 2 weeks. Of those who coughed for two weeks or 
more, 250 (12.7%) had smear positive PTB, and of those who had coughed for less 
than two weeks, 21 (8.7%) had smear positive PTB. There was no statistically 
significant difference in the proportion of smear positive tuberculosis among the two 
comparison groups (Pearson Chi-Square 3.2; p = 0.074). 
The proportion of smear positive TB patients among women with cough attending FP 
and MCH clinics was 3.8%. Out of 749 women with cough, regardless of duration, 
attending FP and MCH clinics, 529 (70.6%) were from MCH clinics. Six hundred 
and sixteen (82.2%) patients had coughed for less than two weeks compared to 133 
(17.8%), who had coughed for two or more weeks. Among 616 TB suspects, 14 
(2.3%) were smear positive TB patients, and of the 133 who had coughed for two or 
more weeks, 13 (9.8%) were smear positive TB patients. Risk factors associated with 
smear positive results included  attended more than one visit to any facility prior to 
diagnosis (OR = 6.8; 95%CI 2.57–18.0) and having HIV/AIDS (OR = 4.4; 95%CI 
1.65–11.96). Long duration of cough was not a risk factor for being smear positive 
(OR = 1.6; 95%CI 0.59–4.49). 
Out of 226 patients enrolled for studying delays in TB detection in Pwani region, 
results were available for 206. The majority (66.5%) of the patients were males. 
Mean age for males and females was 37.3 and 33.7 years, respectively. Mean (SD) 
total delay before initiation of treatment was 125.5 (98.5) days (median 90 days). Out 
of 206 patients, 79 (38.4%) delayed to seek TB healthcare. Health facility delay was 
observed among 121 (58.7%) patients. Risk factors for patients’ delay was poor 
knowledge that chest pain may be a TB symptom (OR= 2.9; 95%CI 1.20- 7.03) and 
the belief that TB is always associated with HIV/AIDS (OR=2.7; 95%CI 1.39-5.23). 
Patients who presented with chest pain were (OR= 0.2; 95%CI 0.10-0.61) less likely 
to delay compared to those with no chest pain.   
One hundred and twenty three TB patients were enrolled for studying patient and 
household costs for TB diagnosis. The majority (53.7%) were males. The mean age 
for male and female patients was 34.8 and 37.0 (14.8) years, respectively. Before TB 
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diagnosis, overall, TB patients lost 46% of their mean monthly income. At individual 
level, poor patients had relatively higher mean loss of income (15 USD, 52%) of 
mean monthly income compared to less poor patients (45 USD equivalent to 46%) of 
mean monthly income. Thirty eight (39.2%) patients stopped working due to TB 
illness with an average of 77 days off. Before diagnosis, overall, tuberculosis caused 
on average 25 patients lost work days. Among patients who stopped working, 17 
(47.7%) were head and the main bread earner for their households whereas, 5 
(55.6%) were poor compared to 12 (41.4%) less poor. At the household level, overall 
household mean monthly income dropped by 28%. Poor households had relatively 
higher loss of monthly income compared to less poor. In-direct cost contributed to 
almost two thirds of the total cost. While poor households spent 150% of their mean 
monthly income, less poor spent 43%.  
Conclusions 
• Detection of smear positive PTB among patients who coughed for less than 
two weeks, was as high as for those who coughed for two weeks or more. 
• Almost four percent of women with cough attending MCH and FP were smear 
positive TB patients.  
• There is a considerable delay in TB diagnosis and treatment in Pwani, mainly 
due to patients’ delay. 
• The economic burden of TB health care seeking is high, especially for the 
poorest households.  
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1. INTRODUCTION AND LITERATURE REVIEW 
1.1 General 
Tuberculosis is a growing threat, a global health burden and the leading cause of 
adult death above any other infectious disease especially in the developing world [1]. 
The HIV/AIDS pandemic has caused a resurgence of TB. Globally, it is estimated 
that, 7-15% of new cases of TB are also HIV/AIDS co-infected; Sub Saharan Africa 
accounts for 75% of these case [1-3]. Nearly 60% of HIV infected individuals in Sub 
Saharan Africa are women, but TB case detection in many countries is lower in 
women than in men[4]. In Tanzania, women account for 58% of all HIV infected 
cases but less than two fifths of new smear positive TB cases notified in the country 
in 2007 were women [5-6]. WHO recommends TB case detection through passive 
case finding rather than active case finding. However, TB case detection through 
passive case finding has remained lower in many sub Saharan countries and active 
case finding through mass screening and house-to-house surveys were neither 
practical nor cost effective [7-8] .  
1.2 Pulmonary tuberculosis diseases, causes and transmission. 
Pulmonary tuberculosis is a lung disease caused by Mycobacterium tuberculosis or 
occasionally by other bacteria that are members of what is known as the 
mycobacterium complex (m. bovis, m. africanum, m. microti, m. cannetti m. 
pinnipedii and m. caprae).  
A typical pulmonary tuberculosis disease is characterised by chronic cough with or 
without blood stained sputum, low grade evening fever, weight loss, night sweat, 
chest tightness and chest pain. The micro-organisms usually enter the body by 
inhalation of infected droplet nuclei from a person with pulmonary tuberculosis. 
Individual risk of infection depends on the concentration of infected droplets in the 
 16
air, extent of exposure to droplei nuclei and the susceptibility of an individual to 
infection [9]. Good ventilation removes nuclei droplets and so prevents nuclei from 
being inhaled by a person. Direct sunlight kills the tubercle bacilli within minutes, but 
they can survive in the dark for many hours (24-48 hours) [9]. Sputum smear-positive 
pulmonary tuberculosis patients are much more infectious than those with smear-
negative sputum [10]. 
1.3 TB and HIV 
The natural history of many diseases including TB has been reverted by HIV/AIDS. 
The advent of the HIV/AIDS pandemic has lead to an increase of TB especially in 
Sub Saharan Africa [1-2, 11]. Though globally, TB prevalence is on a decline by 
more than 20 percent, the disease has tripled in the high burden HIV countries [12]. 
HIV has been the driving force for TB and has modified the natural history of  the TB 
disease. While, as earlier stated,  7-15% of all new TB cases in adults are also HIV 
co-infected globally, in WHO African region the figure is 31% and in Tanzania is 
even higher at 50% [2-3, 6]. The diagnosis of tuberculosis is more difficult in 
individuals with HIV/AIDS [13]. Immunosuppression caused by HIV/AIDS 
predisposes a previously TB infected individual to develop disease [14] . The annual 
risk of developing TB disease in a person co infected with HIV/AIDS increases about 
20 times, from 0.4% to 8% [14]. TB/HIV co infected individuals usually have 
atypical TB presentation [15]. With the advent of HIV/AIDS, there is increase in 
extra pulmonary TB cases (EPTB), atypical findings in chest x-ray and increase in 
smear negative pulmonary TB cases [15-16].  
1.4 Global TB burden 
It is estimated that, one third of the world’s population is infected with TB [1]. One in 
ten infected people develops active TB in their life time, and 1.8 million people die 
from the disease annually [1]. Tuberculosis is disproportionally distributed globally 
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with the majority of new TB cases occurring in Asia and Sub Saharan Africa [1, 17-
18]. The proportion of people who become sick with TB each year is stable or falling 
worldwide, but the absolute number of new cases is still increasing, partly because of 
population growth [19]. Regional comparisons of the estimated number of cases in 
2007 show that most were in Asia (55%) and Africa (31%) [1]. Nearly 80% of the 
global burden of tuberculosis is contributed by only 22 countries. In 2006 and 2007,  
Tanzania ranked 14 and 15 respectively [1, 19]. The top five countries with high TB 
burden are India, China, Indonesia, Nigeria and South Africa [1].    
1.5 The burden of tuberculosis in Tanzania. 
In more than twenty years after launching of the National Tuberculosis and Leprosy 
Programme (NTLP) in Tanzania, tuberculosis continues to be among the major 
public health problems in the country. Following the advent of the HIV/AIDS 
epidemic in the country, the number of tuberculosis cases has steadily increased from 
11,753 in 1983 to about 62,092 in the year 2007, more than five-folds [20]. The 
majority appear in the economically active age group (15-54 years), the same age 
group affected by HIV/AIDS [20-21]. The situation is worse in urban areas like Dar-
es-Salaam, which for almost two decades has contributed about 25% of cases notified 
in the country [20]. Apart from HIV/AIDS, other factors that contribute to the rapid 
increase of tuberculosis in Tanzania include population growth and urbanisation [6, 
21]. A study by Range et al, showed that, between 1991-1998 TB case notifications 
rates increased from 54 to 74 per 100,000 populations [21]. Sixty percent of this 
increase was related to HIV/AIDS [21]. Annual reports of the NTLP have shown the 
same trends [20]. According to these reports, between 2006 and 2007, the notification 
rate per 100,000 population declined by 3.3% [6]. Case detection rate for new smear 
positive cases was 51% in 2007 while that of all new cases was 48% [1]. Out of all 
TB cases notified in 2007, ninety three percent were new case [1].    
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1.6 Global Policies and challenges for Tuberculosis control 
For decades, tuberculosis control has been a major subject of concern on the world 
agenda. In the year 1991, the world health Assembly recognised TB to be a major 
neglected health problem and called for much greater international effort to control 
the disease. However, for almost two decades now the situation has not improved 
especially in low income countries, where the burden is overshadowed by stigma, 
ignorance, poverty and poor diagnostic facilities [22-25]. WHO estimates that case 
detection in many countries is very low [1], therefore, large numbers of cases are 
undiagnosed and continue to spread the infection in various communities. The WHO 
has set two targets for global TB control: 70% detection of incident cases, and 85% 
successful treatment. Theoretically, reduction of TB is expected once these two 
targets are met. The global target of detecting at least 70% of TB cases is still a 
challenge in most of the sub Saharan countries. Tuberculosis control aims at reducing 
the spread of infection through early case detection and prompt treatment. It is 
through case detection that the source of infection can be identified and through early 
treatment that the chain of transmission can be broken and thereby preventing 
unnecessary deaths. Community studies on active case findings have not been 
recommended in developing countries [8, 26-28] partly because of the high cost. 
Pronyk et al in South Africa managed to detect only 6 patients through active case 
finding among a population of 56,000 [27]. In addition to that, most of their patients 
had previously attended a health facility without being recognized as TB suspects, 
implying delayed diagnosis [27]. WHO recommends TB case detection through 
passive rather than active case finding. However, TB case notification is still low in 
most of the developing world. While globally 62% of new smear positive cases were 
detected in 2006 under DOTS, in 2007 the figure was 63% [1].  Overall treatment 
success rate in 2007 was 86%, slightly above WHO target of 85%  [1].  While good 
TB treatment success rates has been achieved under DOTS, low case detection rates 
remain an obstacle to the long-term success of TB control programs [1, 29-30].   
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1.7 Active TB case finding: Historical perspective and success. 
After the advent of anti-TB drugs, there was a significant change of TB case finding, 
from case detection and isolation to case detection and treatment. Different TB case 
detection strategies have been used over the last century from mass radiography, 
house to house surveys, out-patient case detection and enhanced case findings. Mass 
radiography was the first active case finding strategy in industrialized countries 
before 1960’s [7]. In 1945, mass radiography was conducted in the developing world 
where a greater proportion of army recruits from India were found to have TB [7].  
Another mass radiography study conducted in Delhi, India among 90% of civil 
servants revealed a significant number of undiagnosed TB [7] . However, in the late 
1950’s, the use of mass radiography in the developing world was found not to be 
practical, primarily due to its high cost and under-developed public health 
infrastructures [31]. From early 1960s, studies in developing countries revealed that 
the majority of patients were aware of their TB symptoms and had sought care for 
these symptoms prior to their diagnosis [7, 32]. It was therefore concluded that, with 
the strong health system infrastructures, the majority of symptomatic cases could be 
detected [7, 32].  From the 1970’s and onwards, house-to-house TB case detection 
studies using different methodologies from symptom survey, tuberculin skin testing 
and mass radiography were conducted. House-to-house symptoms screening and 
sputum collection in South Korea found health facilities screening to be more 
efficient, even though household visits detected almost three times more cases than 
the health facilities screening [7]. A prevalence survey conducted in KwaZulu, South 
Africa concluded that active case finding would be necessary if TB incidence was to 
be reduced; however it was too costly and therefore impractical [33]. Kenyan 
investigators tested several different case detection strategies in a series of studies in 
the late 1970s and 1980s [34-36]. Though house-to-house surveys yielded the highest 
proportion of the estimated annual incidence of smear-positive cases, it was found to 
be cumbersome, costly and time-consuming, and therefore considered to be an 
impractical strategy for many developing countries with limited resources [26, 28, 
36].  
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1.8 Tanzania Tuberculosis control and case detection rates. 
Tanzania total population is projected at 38 million people [37] of which the majority 
are females. The healthcare system in Tanzania is fairly well distributed with over 
90% of the population living within 10km from a health facility [38-39]. Tanzania is 
among the countries with the highest TB and HIV burdens [1, 4]. The HIV 
prevalence among TB patients is almost 50% [1], higher in urban settings compared 
to rural areas. TB case detection in Tanzania is mainly through passive case finding. 
Passive as opposed to active TB case finding is when symptomatic patients present 
themselves to the outpatients department (OPD) with a cough of two or more weeks 
with or without accompanying symptoms, and are screened for TB. None of the case 
finding activities are conducted at the maternal and child health (MCH) clinics or 
family planning (FP) clinics.  Directly Observed Short course therapy (DOTS) 
coverage in Tanzania is 100% but for more than a decade case detection rates of new 
smear positives cases has shown a decreasing tendency [1]. TB diagnosis is mainly 
by smear microscope and TB activities are monitored routinely through NTLP [40].  
1.9 Challenges for early TB case finding 
A successful TB program requires specific behaviours from both patients and 
healthcare providers in order to facilitate successful TB case detection and prompt 
treatment. In many communities where TB incidence  is high, the major force driving 
the epidemic is transmission, and long delay from the onset of disease to start of 
treatment. Patients’ health seeking behaviour and factors within the healthcare 
systems are the main determinants of the delay. 
Health system: Healthcare providers are expected to successfully offer sputum smear 
examination to patients, conduct tests adequately and timely, and monitor TB 
medicine intake [1, 40]. However, inadequate TB knowledge among health workers 
and the lack of diagnostic facilities may delay patients diagnosis and treatment [41]. 
Studies have shown that, the majority of people with cough seek appropriate help 
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early but the problem is within the healthcare system. Less than a quarter of people 
who attended a health facility in Ghana with cough of more than 2 weeks were 
investigated for TB at their first visit [42]. Another study from Kampala Uganda 
showed a total delay of up to 22 weeks among those who first approached 
government health centres. The major contributor to the total delay was health system 
[43]. Studies conducted in Botswana, Ghana and Ethiopia identified healthcare 
system as the main cause of delay as well [44-46].  
Patients health seeking behaviour: How an individual define his/her ill-health 
condition depends on a variety of factors, such as ignorance, poverty and stigma 
associated with the disease. Lack of knowledge may lead to under- or over-estimation 
of the duration of illness [47]. Poverty and ignorance can also influence individual 
health seeking behaviour. It can influence the way the poor perceive their illness, 
when and where to seek care, type and quality of care received and whether they 
achieve successful outcome or not. Such barriers delay health care seeking and 
lengthen the overall process of achieving cure, resulting in greater expense and lost 
income, which in turn increase poverty [48-49]. Late reporting to a health facility 
after onset of cough symptoms was among the causes of delay to initiate TB 
treatment in Mwanza and Dar es Salaam [41, 50]. A significant number of patients 
first reported to traditional healers in Mwanza [50] which may contribute to their 
delay. A study conducted in Kampala Uganda revealed that the majority of patients 
first presented to a private clinic or pharmacy after having respiratory symptoms, thus 
delaying to seek proper medical care [43]. Due to the similarities in symptoms 
between TB and HIV/AIDS, TB is highly stigmatized [51-52]. A study conducted in 
a high HIV prevalence area in Thailand revealed that TB is highly stigmatized 
because people with symptoms related to TB are regarded as having HIV rather than 
TB [53]. This could be a major drawback in case detection as patients may fear to 
present themselves for care, especially those patients who suspected themselves of 
having HIV/AIDS [53-54].  
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1.10 TB in women: burden and historical perspective.  
TB kills more women than all causes of maternal death combined [55].  Globally less 
than half of the new smear positive TB cases notified in 2007 were females [1]. In 
Tanzania less than two fifth of smear positive TB patients detected in 2005 were 
females [6]. The impact of TB on women is more intense when considering repeated 
child bearing, malnutrition and low social economic status of women, HIV/AIDS and 
stigma attached to TB.  Once infected with TB, women in the reproductive age group 
are more susceptible to develop active TB than men of the same age group [56]. TB 
in pregnant women has been a topic of concern and controversy. It was believed that, 
enlarging gravid uterus improved the course of TB disease [57].  However, in the 
middle of 20th century it was shown that change of intra-thoracic pressure due to 
descend of the diaphragm following delivery, accompanied by hormonal fluctuation 
and low nutrition increase the susceptibility to pulmonary TB  [58]. Towards the 
beginning of 21st century, it was revealed that, if properly and adequate treated with 
anti-TB chemotherapy, pregnant women are not at a higher risk than non pregnant 
women [59]. Several factors have been associated with low case detection among 
women, some being cultural, social, low social economic status of women and 
women’s tendency of placing family matters above their own health [60-61]. Under-
reporting of TB cases among women could explain the low notification rate of TB 
among women since it is known that the prevalence of infection is similar in males 
and females until adolescence [62].  After adolescence TB notification rates in many 
developing countries show men's disease rates exceeding that of women [62]. This 
have been associated with greater exposure because of higher social and economic 
activities among adult males than females [63]. 
1.11 Expanding TB case finding activities to other clinics. 
Extension of TB case finding activities to other clinics has been recommended in 
other studies and may contribute to reducing delay in initiating treatment. A study 
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conducted in Haiti showed that a high proportion of people with cough attending 
voluntary HIV counselling and testing (VCT) clinics had TB [64] and it was 
recommended to extend TB case finding activities to VCT clinics.  Furthermore, TB 
screening during antenatal care (ANC) was recommended in a study by Kali on 
combining PMTCT clinics with active case finding for tuberculosis [65]. In this 
study, significant numbers of HIV-infected pregnant women were found to have 
previously undiagnosed, smear-negative, culture-confirmed TB. Sangala et al in 
Malawi demonstrated that intervention aiming at extending TB case finding to ANC 
was acceptable [66]. In addition to the acceptability of extending TB case finding 
activities to other clinics, screening of patients with short duration of cough of one 
week has revealed undiagnosed smear positive TB cases in Malawi [67]. 
Furthermore, a study conducted in Brazil revealed that the probability of having TB 
was not related to cough duration [68]. 
1.12 Economic burden of TB 
The burden of tuberculosis in Africa and other low income countries is significant.  It 
affects social and economic livelihoods of the individual patients, families and the 
country economy at large. TB affects the economic welfare of people in at least two 
ways. First, the disease necessitates costly healthcare seeking thus reducing the 
proportion of income available for other types of consumption and investments. 
Second, TB sickness reduces the ability of people to perform their usual productive 
activities, further diminishing the economic capabilities of poor households [69].   
High direct costs before TB diagnosis, during the course of diagnosis and during 
treatment among patients and households have been reported in other studies [48, 69-
70]. The economic burden to TB patients just before registration into a TB clinic was 
for example demonstrated to be a barrier for prompt diagnosis in Zambia [69].  A 
study in Bangladesh showed that, households with a TB patient spend 20% of the 
households annual income on private medical expenses before the patient visited 
public TB clinic [48]. The average patient and household costs before TB diagnosis 
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was 209% of the mean monthly income in Malawi and 158% in Zambia [69, 71]. In a 
study conducted in Zambia, one third of TB patients stopped working due to TB 
illness [69]. Furthermore, the majority of wage earners had to stop work because of 
TB in Uganda, where subsistence farmers reported lower productivity for the same 
reason [70]. It was further revealed that the average time lost was unbearable and that 
patients on average lost income comparable to almost  90% of Gross Domestic 
Product (GDP) per capita [70].  
Loss of income and increased expenditure following TB illness may subject poor 
families to remain with debt and, in consequence, having to sell their assets, which 
subsequently may result in increased poverty.  Two fifths of households with TB 
patient in Bangladesh sold their assets to cover the cost associated with TB [48]. 
Research in India revealed that one fifth of rural patients and two fifth of urban 
patients borrowed money to pay for expenses due to TB [49]. All these findings 
suggest that reducing diagnostic delay could reduce costs, improve welfare, increase 
households’ productivity and their income. High pre-diagnosis costs can be 
substantial especially among the poor and may deter patients from seeking care early 
and therefore jeopardize the efforts made by National TB control programs in 
meeting the Millennium development goals. 
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2. RATIONALE OF THE STUDY AND STUDY OBJECTIVES 
2.1 Rationale of the study: 
Infectious pulmonary tuberculosis is often not detected until a late stage, even  
though patients may have attended health facilities during the initial stage of the 
disease [41, 50, 72]. The period during which infected people fall ill, but before they 
are diagnosed and effectively treated, is critical because of substantial pre-diagnosis 
costs. This is a particular cause for worry because of long delay in TB case detection 
leading to ongoing transmission caused by poor patients who can’t afford pre 
diagnosis expenses. Thus, there is a need for looking into other ways of detecting TB 
cases early within the recommended passive case finding strategy in order to reduce 
delay and cost.  
The majority of Tanzanian are poor, they consume less than the national poverty line 
of 0.4USD per person per day [39]. In the year 2007, the average monthly household 
income at national level was 31USD [39], while for a household in Dar es Salaam the 
average was 63 USD [39].  On clinical and epidemiological grounds, emphasis has 
rightly always been laid on early diagnosis of tuberculosis. But due to ignorance and 
poverty, delay in TB case detection is still a problem in many African countries 
causing high patients and households cots. Like in many other developing countries, 
TB case-finding in Tanzania depend on self-referred patients to the health facilities. 
A patient must have cough of two weeks or more to be suspected [40] and only 
patients with long duration of cough are screened for TB by smear microscopy [40, 
73]. Under current passive case finding, Tanzania as a country is detecting less than 
WHO estimates, since only those who report to the OPD with chronic cough with or 
without some other constitutional symptoms for TB are suspected and investigated. 
However, with the current health system situation in the country, it is less likely for 
patients with short duration of cough to queue at the health facility for care; most of 
them will first take self medication from drug shops and pharmacies as reported in 
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other studies [46, 74]. Furthermore, ignorance may also make patients to 
underestimate the duration of their illness as it was previously reported in Tanzania 
[47] and therefore, reduce their chances of being suspected early. In addition, it is not 
necessary for someone to cough for two weeks or more for mycobacterium to be 
evident in the sputum[68]. Moreover, incorporation into maternal and child health 
clinics, information about the risks of tuberculosis in young women was 
recommended by Holmes in 1998 [62]. 
Despite low TB case detection in Tanzania, no single study has tried to intensify 
passive TB case finding, by expanding TB case detection activities into FP and MCH 
clinics as well as screening all patients with cough, regardless of the duration, 
attending OPD, FP and MCH clinics. Pre-diagnosis costs and how they may affect 
health seeking behaviour are also not well documented. The present study was 
conducted under normal operational conditions using the routine diagnostic technique 
for TB. Cough is a primary symptom used in this study as advocated by NTLP [40]. 
A study from India also found that, using cough as a primary symptom among OPD 
attendees, 65% of all prevalent smear positive TB cases would be detected [75].  
Sputum microscopy is the main diagnostic technique for TB as it is cheap and quick, 
most available and reliable. Sputum culture is not done as a routine procedure, but 
can be done in zonal laboratories and in the National Reference Laboratory for drug 
sensitivity surveillance  and follow up of retreatment patients with treatment failure 
or relapse [40].  
2.2 Goal  
The main goal of the study was to contribute towards reducing diagnostic delay and 
identifying factors associated with tuberculosis management delay in Coastal (Pwani) 
regions.  
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2.3 Main objective 
To establish the effect of intensifying passive TB case finding: study delays in TB 
management and determine patients’ and households’ costs associated with TB 
passive case finding in Dar es Salaam and Pwani regions, Tanzania.  
2.4 Specific objectives 
i. To determine the prevalence of pulmonary tuberculosis among all patients 
who reported cough, regardless of duration, attending OPD in Dar es 
Salaam. 
ii. To determine the proportion of smear positive TB cases among women 
with cough attending FP and MCH clinics in Dar es Salaam. 
iii. To determine the magnitude of, and factors responsible for TB 
management delay in Pwani.  
iv. To determine patients’ and households’ cost associated with TB healthcare  
      seeking in Dar es Salaam.  
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3. METHODS 
3.1 Study design and area. 
We conducted a cross sectional hospital based study in Dar es Salaam and Pwani 
region between 2007 and 2008. The two regions are adjacent to each other and they 
are located along the coastal area of Tanzania as shown in figure 1 below.  
Coast (Pwani) region is bordered to the East by Dar-es-Salaam and the Indian Ocean, 
to the North by the Tanga Region, to the South by the Lindi Region and to the West 
by the Morogoro Region. Residents of Pwanit are of different ethnicity, though 
mainly Zaramo. They are mostly engaged in low income generating activities and 
small scale farming. According to the 2002 census report, Pwani region has a total 
population of 889,154 with 440,161 males and 448,993 females [76]. The region is 
administratively divided into six districts namely Bagamoyo, Kibaha, Kisarawe, 
Mkuranga, Rufiji and Mafia. The study was conducted in Bagamoyo, Kibaha, 
Mkuranga and Kisarawe. The total population in the four districts where we 
conducted our study was as follows; Bagamoyo 230,164; Kibaha132, 045; Kisarawe 
95,614 and Mkuranga187, 428 [76]. The literacy level among males and females in 
Pwani  was 75.7% and 72.5% respectively, compared to 80.0% and 67.3% for the 
country at large [77]. The majority of the residents live below one dollar a day [39]. 
HIV/AIDS prevalence in the region is 5.3% [78] slightly lower than the national 
figure of 6.0%. TB case notification is still very low like in other regions of Tanzania 
[20].  
Dar es Salaam is the country's richest city and a regionally important economic 
centre. The city is administratively divided into three municipalities namely 
Kinondoni to the north, Ilala in the center and Temeke to the south of the city. The 
study was conducted in all municipalities of Dar es Salaam. According to the 2002 
census report, Dar es Salaam has a total population of 2,497,940 with 1,261,077 
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males and 1,236,863 females [76]. Kinondoni alone has the total population of 
1,088,867 with 549,929 males and 538,938 females. Ilala and Temeke have the total 
population of 637,573 and 771,500 respectively. Total male and female population in 
Ilala is 321,903 and 315,670 respectively, while that of Temeke is 389,245 males and 
382,255 females [76].  The population is relatively young with the majority aged less 
than 25 years [76]. Population growth following urbanization is also high making the 
city to have mixed ethnicity. Since Dar es Salaam is close to Pwani region, residents 
between the two regions easily interact. The surrounding villages and towns of Pwani 
focus on Dar es Salaam as the market for their products and the source of supplies 
and consumer goods. The majority of the residents are involved in small scale 
businesses. Percent literacy level among males and females in Dar es Salaam was 
94.5% and 87.4% respectively [77]. For the past ten years, Dar es Salaam has 
accounted for a quarter of all TB cases notified in the country. Like in other parts of 
the country, TB services are free in all government facilities. Health facilities in Dar 
es Salaam are well distributed, while 75% of the population lives within 2km from a 
health facility, more than 95% are within 6 kilometers [39].  
 
Figure I: Map of Tanzania: 
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3.2 Study population. 
3.2.1 Selection of districts. 
 
All three municipals of Dar es Salaam and four out of six districts of Pwani regions 
were included in the study. From the list of all districts in Pwani, we randomly 
selected four namely; Bagamoyo, Kibaha, Kisarawe and Mkuranga.  
3.2.2 Selection of health facilities:  
In Dar es Salaam, the study included municipal hospitals and government health 
centers. All municipal hospitals namely; Temeke, Ilala and Mwananyamala were 
purposefully selected due to their large number of patients. In addition, we also 
selected randomly one health center from each municipal from a list of all 
government health centers. The selected health centers included Zakiem in Temeke, 
Tabata in Ilala, and Magomeni  in Kinondoni, making a total of three health centers 
in Dar es Salaam.   
In the four districts of Pwani region, we included all four district hospitals plus a 
random sample of 10% of all health facilities which offer TB services. In total we 
included the four hospitals, four health centers and eight dispensaries from Pwani 
region.  
3.2.3 Selection of study participants:  
Study participants for detection of pulmonary tuberculosis among patients with cough 
attending Outpatient departments in Dar Es Salaam (paper I) involved patients aged 5 
years and above and complaining of cough. Study participants for pulmonary 
tuberculosis among women with cough attending FP and MCH clinics in Dar Es 
Salaam (paper II) involved women with cough aged 15 years and above. All 
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participants enrolled through OPD, FP and MCH were screened for TB by sputum 
microscopy, regardless of the duration of cough.  
Exclusion criteria for the study participants (paper I and II) comprised patients who 
were already diagnosed with tuberculosis at the time of the study or who were 
already on anti TB drugs, non-consenting patients and patients who were unable to 
collaborate because of psychiatric disease.  
To study delays in tuberculosis case detection (Paper III) we recruited smear positive 
TB patients diagnosed as having TB within three months prior to the commencement 
of the study in Pwani region.  
Study participants for patients and household costs associated with TB health care 
seeking (paper IV) included patients aged 15 years and above who had just been 
diagnosed with TB. Patients were excluded if they were less than fifteen years of age, 
insane or non-consenting. 
 Table 1: Summary of the study participants and tools. 
Paper Title Study population Number of 
patients/sputum 
samples 
collected. 
Study tools 
Paper 
I 
Detection of pulmonary 
tuberculosis among patients with 
cough attending outpatient 
departments in Dar Es Salaam, 
Tanzania: does duration of cough 
matter? 
All patients aged five 
years and above, with 
cough, regardless of 
duration, attending 
out-patient 
department. 
2274 patients OPD 
registers, 
laboratory 
registers/ 
records. 
Paper 
II 
Pulmonary tuberculosis among 
women with cough attending FP 
Women with cough, 
regardless of 
749 women FP and MCH 
registers, 
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and MCH clinics in Dar es 
Salaam, Tanzania. 
duration, attending 
FP and MCH clinics 
Laboratory 
registers/reco
rds. 
Paper 
III 
Delay in Tuberculosis case 
detection in Pwani Region, 
Tanzania. A cross sectional 
Study. 
Smear positive TB 
patients ages 15 years 
and above. 
226 smear 
positive TB 
patients 
Structured 
questionnaire
s, TB 
treatment 
cards 
Paper 
IV 
 
 
Patients and household cost 
associated with tuberculosis 
diagnosis: Can Tanzanian poor 
afford free TB diagnosis 
services? 
Patients aged 15 
years and above and 
who had just been 
diagnosed with TB. 
123 TB patients Structured 
questionnaire
s 
 
 
3.3 Data collection methods: 
We recruited study participants in four different locations: general OPD clinics, MCH 
clinics, FP clinics and DOTS clinics.  
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Figure II: Flow chart of study subjects. 
 
 
 
 
 
3.3.1 Training of personnel.   
Before commencement of the study, we trained the research team on the study 
questionnaires and data collection procedures. The team comprised of research 
coordinators, clinical officers, laboratory personnel and research assistants.  
3.3.2 Recruitment of study participants from the OPD, MCH and FP clinics: 
In the OPD clinics, clinical officers registered in a separate study register all patients 
reported to have been coughing. At the MCH and FP clinics, clinical officers asked 
the patients whether they had a cough. If so, they requested the patients to submit 
2274 patients 
with cough, 
regardless of 
duration, 
attending 
OPD. 
226 smear 
positive TB 
patients 
attending 
DOTS clinics. 
749 women 
with cough, 
regardless of 
duration, 
attending FP 
and MCH 
123 
recently 
diagnosed 
TB 
patients  
349 TB patients 
from DOTS clinics 
3,023 TB suspects 
from OPD, MCH and 
All study subjects  
3,372. 
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sputum samples as per national guidelines for TB suspects. Variables recorded were 
name, socio-demographic characteristics, area of residence, cough duration in days or 
weeks, areas they visited for care, number of visits made and sputum results. Sputum 
request forms were used for sputum investigations. Study laboratory registers were 
used to record patients smear results.  
3.3.3 Recruitment of study participants and data collection for assessing delay in TB 
management: 
We interviewed the patients using a structured questionnaire which included open 
and close-ended questions. To ensure that all smear positive patients were enrolled, 
we identified all smear positive patients who had been diagnosed within three months 
prior to the day of interview. A maximum of two weeks was used to collect 
information at each facility, depending on the number of smear positive patients 
available in the facility and number of patients coming to collect drugs. The 
information collected included: socio-demographic characteristics, knowledge about 
TB, place of first consultation and time spent to go to the nearest health facility. 
Other information collected were date of onset of pulmonary symptoms, date of first 
visit to a health facility, dates of collection of all three sputum samples, and date of 
starting treatment. If a patient did not remember the exact dates, then the patient was 
asked if it was at the beginning of the month, at mid month or at the end of the 
month. The beginning of the month was labeled as 5th, mid month was labeled as 
15th and end of the month was labeled as 25th of the respective month. Patient TB 
treatment cards were also used to look at the date treatment was started.  
3.3.4  Recruitment of study participants from the DOTS Clinics for identifying patients 
and households cost before TB diagnosis: 
In all facilities, a list of all TB patients aged 15 years and above who had been 
diagnosed within the last two days was made as they appeared in the TB treatment 
registers. From this list, every second patient who came for TB treatment was 
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selected, and after informed verbal consent, they were interviewed using a structured 
questionnaire. Associated healthcare seeking expenditures and loss of income 
incurred by the patients, caregivers and families while seeking care for TB symptoms 
were registered. Interviewers were trained to elicit answers with a series of 
supplementary questions. Patients were asked about when their current TB symptoms 
started, where they visited for healthcare, number of visits made to each healthcare 
facility, including traditional healers, number of visits they were escorted on, as well 
as travel time and cost they encountered. Other information requested included: time 
spent in each facility, consultation, laboratory and treatment cost. Cost for buying 
food or drink while going to each place and any other out of pocket cost was also 
noted. In addition, we asked questions concerning income from different sources for 
each member of the household before and during illness. Questionnaires also 
contained information on patients’ socio-demographic characteristics.  
Cost estimation: The conceptual framework for the measurement of patient and 
household cost were drawn from general guidelines for cost analysis [79]. Costs were 
estimated during TB healthcare seeking, which is the period from the onset of 
symptoms to the diagnosis. Two types of costs commonly associated with using 
healthcare services were measured: direct and indirect cost. Direct costs include all 
financial expenditure by the patient and care taker such as on consultation, 
registration, traditional healers and remedies, investigations, drugs and food bought 
when seeking care. Direct costs also included transport costs – the amount spent by 
the patient and/or caregiver on transport to travel to each health facility. Indirect costs 
included patients’ and households’ income loss, and loss of time from production and 
employment activities related to disease and accessing care. Economic losses from all 
sources were also calculated. We estimated time loss by assuming that there are 22 
working days in a month and 8 working hours in a day. Time loss was converted to 
monetary values based on the average reported patient income before illness. Patients 
with no income before illness were excluded in the calculation of mean patients’ 
income.     
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3.3.5 Collection of sputum, microbiology and diagnosis of TB. 
All patients were requested to submit three sputum samples in a form of spot, 
morning, and spot. Spot specimens were collected on the day the patient is suspected 
to have tuberculosis, morning samples were collected early in the morning of the 
second day and the third specimen was collected on submission of the morning 
specimen. A total of 9069 sputum samples were collected in a 50 ml screw cap. 
Smear microscopy was done by routine Ziehl Nielsen staining technique for acid fast 
bacilli in each respective facility laboratory. A patient was diagnosed to be smear 
positive if he/she had at least two sputum smears positive for acid fast bacilli. Smear 
positive results were classified and recorded according to the standard 
WHO/IUATLD protocol. Acid Fast Bacilli seen per high power field was  classified 
as 1-9 per100 immersion fields, +1 for 10-99AFB per 100 fields, +2 for 1-10 AFB 
per 1 field and +3 for >10 AFB per 1 field.  
3.3.6 Quality control: 
Research assistants were trained on research tools and data collection procedures. In 
addition, training was also conducted to make sure that procedures for smear 
microscopy were according to the National standards. Study clinicians were 
responsible to register all patients with cough and their smear results in the study 
registers. At the end of the week, the study coordinators compared smear results 
recorded in the patients’ registers with patients’ results in the laboratory registers. 
The study was conducted at a time when the Central Tuberculosis Reference 
Laboratory (CTRL) had an ongoing quality assurance project. The quality check for 
the submitted samples was done according to routine National Tuberculosis and 
Leprosy Control Program (NTLP) guidelines [40].  
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3.4 Study Management. 
3.4.1 OPD, MCH, FP and DOTS clinics: 
Clinicians were placed in the OPD of each selected facility as well as at the FP and 
MCH clinics. One laboratory personnel in each facility was responsible for 
performing smear microscopy and record the results in the laboratory registers and 
laboratory request forms. They were also directing patients to send their laboratory 
results to the respective clinicians.  
One research assistant was placed at each of the MCH and FP registration areas. They 
were responsible for asking all women about cough and direct them to study 
clinicians. The research coordinators checked the records filled by clinicians and 
research assistants for completeness and consistency. Their main responsibility was 
to ensure that the study protocol and guidelines were followed. They were also 
responsible for filing the questionnaires and keeping the registers for further review 
by the principal investigator, before data entry. Data was double entered by the data 
entry clerks.  
3.5 Data management and statistical analysis. 
3.5.1 General: 
Completed questionnaires were coded by numbers and double entered in a computer 
software Epi-data version 3.1 [80]. Coding procedure was done to allow computer 
entries of responses for open questions and combinations of multiple responses to 
respective questions in the questionnaire. Cross-checking and data cleaning was done. 
Data was then transferred to Statistical Package for Social Sciences version 11.5 for 
windows (SPSS Inc, Chicago, USA) for analysis. The variables were categorized to 
form groups of interest for comparison analysis.  
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3.5.2  OPD, MCH and FP data:  
The outcome variable was diagnosis of smear positive TB. We explored possible 
associations between cough duration and smear results, clinic of diagnosis, place of 
first presentation and number of visits made prior to diagnosis. Pearson chi- square 
and Wald statistic were used to compare group difference for categorical variables. 
Differences were considered statistically significant if p  5%. We estimated risk 
factors for smear positivity by logistic regression, with 95% confidence interval (CI) 
given for odds ratios (OR), indicating a statistically significant relationship if  the  
95% CI did not include  1. Adjusted OR with 95 % CI were also calculated. Nineteen 
(1.3%) patients had only one smear positive sputum sample and were excluded from 
the analysis.   
3.5.3 DOTS clinic data: 
Risk factors for delay were estimated by bivariate logistic regression with 95% CI 
given for OR.  The means(SDs) and medians (ranges)  were used for estimation of 
time delay from onset of illness to reporting for the first time to health facilities and 
to initiation of treatment.  
3.5.4  Cost analysis:  
We divided our study population into two groups of poor and less poor, using 
average income of 63 USD for Dar es Salaam [39] as cut off. Patients with below 63 
USD were regarded as poor and those above 63 USD as less poor. Mean and median 
direct, indirect and total costs for both patients and households were determined. All 
costs and incomes are presented in USD 2007 and the exchange rate from Tanzanian 
shillings to USD used was TZS 1,279.1 per one USD [39].  
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3.6 Operational definitions 
Patient delay: the time interval between the day of experiencing for the first time one 
of the current pulmonary symptoms to the day the patient sought medical advice for 
the first time. Interval that exceeded 30 days was considered as patient delay [41, 50].  
Health facility delay: the time interval between first consultation at a health facility 
to the day the treatment was initiated. We considered a time interval of more than 5 
days as health facility delay [41].  
Total delay:  the sum of the patient and health facility delay. 
Knowledge about TB: Patients who knew that TB can be spread from one person to 
another by coughing/sneezing were defined as having “good knowledge on TB 
transmission”. Patients who mentioned prolonged cough plus two other symptoms 
from the following: fever, night sweat, chest pain, difficult in breathing, weight loss 
and coughing blood were defined as having “good knowledge of TB symptoms”[41]. 
3.7 Ethical Clearance: 
The proposal was granted ethical clearance by the Tanzania Medical Research 
Coordinating Committee. Permission to conduct the study was also sought from the 
local authorities. Informed verbal consent was obtained from each interviewee before 
enrolment into the study. For those below the age of 18 years permission was sought 
from their parents or caretakers. Patients with one smear positive sputum sample 
(Paper I and II) were referred to the district tuberculosis and leprosy coordinator 
(DTLC) for treatment and follow up using NTLP procedures.  All patients with PTB 
(Paper I and II) were also referred to the DTLC for treatment. Non-TB patients were 
treated according to the diagnosis made.  
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4. KEY FINDINGS   
4.1 Detection of Pulmonary Tuberculosis among Patients with cough attending 
Outpatient departments (Paper 1): 
 We enrolled 2274 patients, out of these, 2214 (97.4%) remembered their cough 
duration. One thousand nine hundred and seventy three patients (89.1%) coughed for 
two weeks or more compared to 241 (10.9%) patients who coughed for less than 2 
weeks. Of those who coughed for two weeks or more, 250 (12.7%) had smear 
positive PTB, and of those who had coughed for less than two weeks, 21 (8.7%) had 
smear positive PTB. There was no statistically significant difference in proportion of 
smear positive tuberculosis between the two comparison groups (Pearson Chi-Square 
3.2; p = 0.074). We therefore concluded that detection of smear positive PTB among 
patients who had coughed for less than two weeks was as high as for those who had 
coughed for more than two weeks among patients attending outpatients departments 
in Dar es Salaam.  
4.2  Pulmonary tuberculosis among women with cough attending clinics for family 
planning and maternal and child health  (Paper II) 
We enrolled all women with a cough, attending family planning clinics and those 
who escorted their children for MCH services.  
We enrolled a total of 749 TB suspects. Five hundred and twenty nine patients 
(70.6%) were from MCH clinics. Mean (SD) age was 27.6 (5.2) years.  A total of 616 
(82.2%) suspects were coughing for less than two weeks as compared to 133 
(17.8%), who coughed for two or more weeks. Among the 616 who had coughed for 
less than two weeks, 14 (2.3%) were smear positive TB patients, and of the 133 who 
had coughed for two or more weeks, 13 (9.8%) were smear positive TB patients. Risk 
factors associated with smear positive results were having attended more than one 
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visit to any facility prior to diagnosis (OR=6.8; 95%CI 2.57- 18.0) and having 
HIV/AIDS (OR= 4.4; 95%CI 1.65-11.96). Long duration of cough was not a risk 
factor for being smear positive (OR=1.6; 95%CI 0.59-4.49). Therefore, we concluded 
that the proportion of smear positive TB patients among women with cough attending 
FP and MCH clinics was 3.8%. The probability of having smear positive TB did not 
depend on cough duration.  
4.3  Delay in tuberculosis case detection (Paper III): 
The aim of this study was to estimate the extent and factors responsible for delay in 
TB case detection in Pwani. Delays were divided into patient, health facility and total 
delay.  
Of the 226 smear positive TB patients enrolled from DOTS clinics, results were 
available for 206. The majority (66.5%) of the patients were males. Mean age for 
males and females were 37.3 and 33.7 years respectively. Mean (SD) total delay was 
125.5 (98.5) days (median 90). Out of 206 patients, 79 (38.35%) delayed to seek TB 
healthcare. Health facility delay was observed among 121 (58.7%) patients. Risk 
factors for patients delay was poor knowledge that chest pain may be a TB symptom 
(OR= 2.9; 95%CI 1.20- 7.03) and the belief that TB is always associated with 
HIV/AIDS (OR=2.7; 95%CI 1.39-5.23). Patients who presented with chest pain were 
(OR= 0.2; 95%CI 0.10-0.61) less likely to delay compared to those with no chest 
pain.   
4.4 Patients and household costs associated with tuberculosis diagnosis (Paper IV):  
One hundred and twenty three patients were enrolled. Based on average income, their 
households were categorised as “poor” or “less poor”. 
We found that, almost two fifths of patients stopped working due to TB illness with 
an average of 77 days off. About two thirds reported income reduction, but there was 
no significant difference between the poor and the less poor. Before diagnosis, 
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overall, tuberculosis caused on average 25 lost work days. About half of the patients 
who stopped working were head and the main bread earner for their households. TB 
patients loose on average almost half of their mean monthly income, and the loss is 
relatively larger for the poorest patients. At the household level, income was most 
severely affected in relative terms for the poorest households, with a reduction of 
36% (13 USD). The overall households mean monthly income for both groups 
dropped by 28% (from USD 134.4 to USD 90.7). The overall total costs for the entire 
household amounted to USD 57, which is equivalent to more that two fifths of the 
mean monthly income. Poor households spent 150% of their mean monthly income 
compared to 43% among the less poor household. Indirect cost contributed to almost 
two thirds of the total cost. We concluded that economic burden of TB healthcare 
seeking is high, especially among the poorest households, and this may severely 
prohibit optimal health seeking behaviour. 
 
 
 43
5. DISCUSSION 
5.1 General methodological issues. 
5.1.1  Study design: 
Cross sectional study design is considered appropriate in assessing disease prevalence 
and therefore important for health planning and resource allocation in resource 
constrained countries. Thus, it was the best study design for our study because we 
were looking at the prevalence of smear positive TB among patients with cough, 
determine extent of delay and cost before TB diagnosis. Although it is not as easy to 
precisely estimate risk in cross sectional studies as it is in cohort studies, the sub 
groups within our study could be compared and odds ratios calculated, so as to 
grossly estimate risk factors as part of cross sectional analytical design. The study 
findings can not be applied to patients with symptoms of TB other than cough (Paper 
I and II) since the study subjects were patients with cough only. Neither can the 
findings be generalized to smear negative and other types of TB (Paper III), as we 
only studied smear positive patients. In addition, private facilities and dispensaries 
were not sampled in our study (paper I, II and IV), this may reduce the 
representativeness and hence generalisability of our findings.  
5.2 Biases: 
5.2.1 Selection bias: 
Our study is subject to selection bias, due to the fact that the universe for this study 
was different from the general population. This may affect generalization of the study 
findings. Selection bias could be avoided by including patients with cough from the 
general population. However, due to financial and time constraints we were not able 
to do a community based survey. Furthermore, TB case finding routines in Tanzania 
 44
are through out-patient departments. Except for research purposes, none of the TB 
case finding activities are conducted at the community level.   
5.3 Recall bias 
Failure to recall the duration of cough (paper I and II) might lead to mislabeling of 
patient and therefore under or over estimating the relationship between duration of 
cough and smear results. However, efforts were made to validate the data by repeated 
questioning. Furthermore, wrong estimations of the dates (paper III) might lead to the 
wrong calculation of delays. However, efforts were made to estimate the dates by 
using periods of the months, holidays etc. As earlier stated, if a patient did not 
remember the exact dates, he/she was asked if it was at the beginning of the month, at 
mid month or at end of the month. The beginning of the month was labeled as 5th, 
mid month was labeled as 15th and end of the month was labeled as 25th of each 
respective month. Patient TB treatment cards were also used to look at the date 
treatment was initiated. Monthly income and cost estimation are also subject to recall 
bias (paper IV). This bias could over- or underestimates the income and cost for TB 
healthcare seeking. In trying to reduce this bias, we validated our data throughout the 
interview by repeated questioning and comparisons of patient cost information with 
known market prices. Though consumption expenditure provide more reliable 
information of household income [39], the mean household income of 134.4 US$ 
before illness obtained in this study is almost similar to the 121.1 US$ which is the 
mean households monthly expenditure for Dar es Salaam reported in 2007 by 
Tanzania households and budgetary surveys (THBS) [39]. The THBS mostly focus 
on consumption expenditure information in poverty analysis [39].  
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5.4 Discussion of the results 
TB case finding 
DOTS coverage in Tanzania is reported to be 100%, [1] but case detection rates of 
new smear positive cases have shown a decreasing tendency from 61% in 1995 to 
51% in 2007 [1]. WHO recommends passive over active case finding. However, 
passive case finding depends on patients self awareness, their ability to seek care, as 
well as affordability of the healthcare. In addition, it also depends on health workers 
knowledge of TB and their alertness in suspecting patients. Ignorance among health 
care workers and TB patients contributed to delay in commencing treatment [41, 43, 
50, 72, 81]. As a consequence, delayed treatment may eventually cost life and 
increase the time spent due to inappropriate and ineffective treatment. The effect is 
even more devastating in the current HIV era where the majority of TB patients are 
also HIV co-infected [1, 6].  Studies suggest that the probability of being smear 
positive does not depend on the duration of  cough, and that the majority of patients 
who report to the health facilities have long duration of cough [50, 68, 82-84], though 
they may report the opposite. Thus, with the DOTS coverage of 100%, efforts are 
needed to increase detection of infectious cases to reverse the current TB situation in 
the country. With the existing HIV trends, it may pay off to consider screening all 
patients with a cough attending OPD as well as expanding TB case findings into 
other clinics.  
Prevalence of smear positive PTB among patients with cough   
The proportion of smear positive pulmonary TB among patients who had coughed for 
less than two weeks was as high as for those who had coughed for two weeks or 
more. This could probably be explained (though not investigated in this study) partly 
by patients’ ignorance and their perception of duration of their illness. In addition, 
such patients could have visited several other health facilities that could have 
suspected TB if medical personnel had proper awareness of TB. However, health 
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seeking behavior of the study participants before they presented at the out-patient 
departments was not investigated. Screening, regardless of cough duration, could 
shorten the duration of TB transmission, as it might reduce diagnostic delays. This is 
important, especially for individuals co-infected with HIV/AIDS, as it could reduce 
morbidity and mortality.   
Thus, taking into consideration the still increasing prevalence of TB/HIV co-
infection, it may pay off to screen for TB, regardless of cough duration, if we really 
intend to eradicate TB by the year 2050 [85]. A study conducted in Brazil, a country 
with prevalence of HIV/AIDS in the adult population of less than 1% and annual 
incidence of smear positive TB patients/100,000 population of 26, reported that the 
probability of detecting TB case does not depend on the duration of cough [68]. Our 
study in Tanzania, where prevalence of HIV/AIDS is 7% and annual incidence of 
new smear positive TB patients/100,000 population is 120, support this finding [1, 
78].     
Effect of expanding TB case detection in MCH and FP clinics. 
The proportion of women with active pulmonary tuberculosis among coughers 
attending MCH and FP clinics was 3.8%. However, none of the TB screening 
activities are done routinely in MCH and FP clinics. Our study indicates that 
pulmonary tuberculosis among MCH and FP attendees with a history of cough is not 
significantly less frequent, when the duration of the cough is shorter than two weeks. 
This is also similar to a study conducted in Brazil [68]. Using the current criteria for 
TB suspicion and only relying on OPD attendees, we might be delaying quite a big 
number of TB cases, since only those who report at the OPD with a cough of more 
than two weeks will be screened for TB under the routine program.  
The majority of the smear positive women were more likely to have visited 
government hospitals and made more than one visit without being suspected.  Failing  
to suspect women is consistent with other studies conducted in Vietnam and 
Tanzania, where factors like poor knowledge of recognizing and reporting TB 
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symptoms and ignorance among healthcare workers were associated with delay in TB 
case detection among women [41, 86]. They could also have first visited healthcare 
posts where they were not properly taken care of, e.g. medical stores and traditional 
healers. Lack of awareness by health personnel and lack of TB diagnostic services 
could also offer an explanation [60, 86-87]. Apart from the delay in being suspected, 
fewer smear positive women than men were detected [1, 17, 82]. Though we did not 
investigate the reason for this, one study has shown that, women are unable to 
produce good and quality sputum [88]. Other risk factors associated with smear 
positive results among women with cough attending MCH and FP clinics were 
having HIV/AIDS. This is contrary to other studies where HIV/AIDS positive 
patients were more likely to be smear negative [89-90]. Though not investigated in 
this study, but shown in another study, possibly the level of immune suppression of 
our study patients was not so severe to the extent of affecting their TB presentation 
[91].  
Worthy to note also is the fact that women who had a long duration of cough were 
more likely to attend MCH than FP clinics. MCH clinics in the study areas were not 
only the clinics for checking under-fives wellbeing but also acted as referral clinics 
for the sick children. Studies have indicated that women place the needs of their 
children and other family activities above their own health. A study in India 
demonstrated that women tended to visit heath facilities for immunization and their 
children’s wellbeing rather than for their own health [61].  
Apparently, the expansion of TB case finding to other clinics and screening approach 
might increase laboratory workload. We therefore recommend that workload- and 
cost effectiveness studies should be conducted to look at the feasibility of the 
screening approaches.  
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Delay in TB case detection.    
Delay in TB case detection is a serious matter; its magnitude has been reported in 
several other studies [41, 43, 50, 72, 92]. Though, TB diagnosis is said to be free of 
charge, the findings from our study show that the ‘free of charge isn’t free’. Before 
TB diagnosis, patients and households not only lose from suspending their jobs, but 
also from unbearable direct and indirect costs. Pre diagnosis high cost may delay 
poor patients from seeking care early. Delayed patients will serve as potential 
reservoirs for infection transmission in their communities. This is especially true 
when considering that one untreated infectious TB case is estimated to infect up to 15 
people annually and over 20 during the natural course of untreated disease [10, 93]. 
Similar to a study conducted in Dar es Salaam, our study indicated that, on average, 
almost two fifth of patients delayed to seek care with a mean duration of more than 
two months [41]. Twenty five percent of patients in our study delayed to start 
treatment until more than three months. Similar results were obtained in Ethiopia 
[72]. The major contributor to the total delay observed in our study was the delay by 
patients (63%), but this was lower than what was reported in Mwanza [50]. Studies in 
Ethiopia and Nigeria also showed dominance of patients delay in the total delay [72, 
81]. Delay in TB case finding jeopardizes the NTLP effort of fighting TB. It also 
increases the cost not only to the patients and households but also to the health 
services because of the prolonged ill health condition leading to repeated 
consultations.  
Factors associated with patients delay 
We have found that patients with poor knowledge that chest pain was one of the TB 
symptoms and those who believe that TB is always associated with HIV/AIDS 
delayed to seek TB healthcare. This finding is similar to a study conducted in Dar es 
Salaam [41]. Similarities of some of TB symptoms with that of HIV/AIDS and 
stigma associated with HIV/AIDS may offer an explanation. Patients with symptoms 
related to TB were regarded as having HIV rather than TB in Thailand [53]. This may 
delay patients from seeking appropriate care because of fear, especially those patients 
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who suspect themselves as having HIV/AIDS [53-54]. In addition, healthcare seeking 
observed in our study differs from other studies. Most patients in our study first 
sought help for their pulmonary symptoms in government hospitals, in contrast to a 
study in India, which showed a high proportion of TB patients first seeking 
healthcare in private facilities [94]. However, despite that, most patients in our study 
first sought healthcare for their pulmonary symptoms in government facilities, yet 
more than half were delayed from being suspected at their first visit, even if many of 
them (78.6%) had prolonged cough of more than two weeks prior to their first 
consultation.  
 
Patients and households cost before diagnosis 
TB imposes a considerable economic toll especially among the poor. The poorest in 
our sample spent on average more than what they received in a month. That means, 
TB left poor families without a buffer for other living cost, making them to depend 
on their relatives and friends for a living. Though not investigated in this study, other 
studies have shown that to cope with the burden of TB, families end up in debt, 
having to sell assets and even withdraw their children from school [48-49, 95]. As a 
consequence, poverty may increase.  
The loss of income following TB healthcare seeking can be devastating. Similar to 
other studies [5-6, 21, 69, 95], our study also indicated that the productive segment of 
the household is mostly affected. Moreover, we found that before TB diagnosis, 
overall household mean monthly income dropped considerably and the poor suffered 
the burden more than the less poor. Income loss following TB healthcare seeking has 
also been reported in other studies conducted in Zambia, Uganda, Malawi and 
Tanzania [69-71, 96]. We found that tuberculosis caused on average 25 patients lost 
work days before diagnosis. This is almost the same as that reported in Zambia and 
Malawi [69, 71].   Though the two studies were conducted 10 years ago, 
unfortunately indirect cost before TB diagnosis seems to be the same.   
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Relatively, overall household cost for TB diagnosis reported in our study is lower 
than that reported in Zambia and Malawi [69, 71]. The household in our sample spent 
on average 57 USD which is equivalent to two fifths of their mean monthly incomes 
unlike Zambians (127%) and Malawi’s (209%) [69, 71]. Difference in total monthly 
income used in calculating the cost in the three studies can serve an explanation. 
Other reasons can be due to the difference in the study areas, study population and 
time since 1998 and 2001 respectively when the study in Zambia and Malawi were 
conducted. Involving patients in the intensive phase in Malawi [71], and recall bias 
may also serve an explanation. Pre-diagnosis high cost has also been reported by 
other authors [97-98]. In our study, the poor spent less on fees, transportation and 
food. However, relative to their total income, poor patients were affected three times 
more than the less poor.   
Cost by area of consultation  
As expected, total cost was high among patients who attended traditional healers and 
private health facilities. Moreover, it is not surprising that the burden of cost in 
private facilities shown in our study is relatively higher among the poor families. 
Similarly, a study from Thailand showed that out of pocket expenditure for TB 
diagnosis was higher among the poor [98]. Studies in Nepal, Botswana and Tanzania 
have shown that patients who first visited traditional healers and/or private facilities 
had a longer delay in TB diagnosis [50, 92, 99-100] and this may also raise the cost 
of healthcare seeking.  
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6. PUBLIC IMPLICATION.  
Our findings indicate that screening, regardless of cough duration, and expanding TB 
case detection activities to FP and MCH clinics might have a significant effect, 
especially among the poor. This could offer several benefits, such as increased early 
TB case detection by reducing TB diagnostic delay, and, as a consequence, reduced 
patients’ cost associated with TB healthcare seeking. This should be of interest to 
NTLP, especially when considering patients’ and health workers’ ignorance, as well 
as atypical manifestations of TB among HIV positive individuals. In particular, this is 
important for individuals co-infected with HIV/AIDS, as it could reduce morbidity 
and mortality associated with delayed TB treatment.  
On the operational research side, investing in conducting workload- and cost 
effectiveness studies of the screening approach, and expansion of the study to include 
other sites, could be important. 
 52
7. CONCLUSIONS 
1. The proportion of pulmonary tuberculosis cases among patients with cough 
attending a general OPD was 12.7% among those who had coughed for 2 
weeks or more, and 8.7% among those who had coughed for less than 2 
weeks. There was no statistically significant difference between the two 
groups 
2. The proportion of smear positive TB patients among women with cough 
attending FP and MCH clinics was 3.8%. HIV infection and visit to any health 
facility prior to diagnosis were risk factors of having smear positive TB. 
3. There was a considerable delay in TB case detection in Pwani, mainly due to 
patients’ delay. Risk factors for delay included misconception about TB and 
HIV and poor knowledge of TB symptoms. 
4. The economic burden of TB health care seeking was high, especially for the 
poorest households. Prior to diagnosis, TB patients lost on average 46% of 
their mean monthly income. At household level, mean monthly income 
dropped by 28%. Before diagnosis, poor households spent 150% of their mean 
monthly income, compared to 43% among the less poor. 
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8. RECOMMENDATIONS. 
1. Special efforts need to be made on intensifying TB case finding to reduce 
diagnostic delays, and, in turn, reduce the cost prior to diagnosis. This may be 
done through: 
o Screening for TB, regardless of cough duration, for all patients who 
report cough at OPD, FP and MCH clinics.  
o Expanding TB case detection activities to other clinics like FP and 
MCH clinics.  
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